NCT02448446View on ClinicalTrials.gov

The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Diabetic Macular EdemaHard Lipid Exudates
Interventions
DRUG

ranibizumab 0.3mg

intravitreally administered

Trial Locations (4)

90404

Retina Partners, Santa Monica

90505

South Coast Retina Center; Carson, McBeath, and Boswell, Inc, Long Beach

South Coast Retina Center; Carson, McBeath, Boswell, Inc, Torrance

92647

South Coast Retina Center; Carson, McBeath, Boswell, Inc, Huntington Beach

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

collaborator

Doheny Image Reading Center

OTHER

collaborator

The Retina Partners

OTHER

lead

South Coast Retina Center; Carson, McBeath, Boswell, Inc.

OTHER